April 29, 2006 Mr. Jordan Siegel Ft. Lauderdale, FL 33308 Dear Jordan:Nabi Biopharmaceuticals • August 2nd, 2006 • Biological products, (no disgnostic substances) • Florida
Company FiledAugust 2nd, 2006 Industry JurisdictionYou have agreed to serve as Senior Vice President, Finance, Treasurer and Chief Financial Officer (“Senior Vice President”) for Nabi Biopharmaceuticals (“Nabi”) which term for purposes of this Agreement shall include affiliates of Nabi Biopharmaceuticals. The following are the terms of such employment:
Change of Control Severance AgreementSeverance Agreement • August 2nd, 2006 • Nabi Biopharmaceuticals • Biological products, (no disgnostic substances) • Florida
Contract Type FiledAugust 2nd, 2006 Company Industry JurisdictionThe Board of Directors of Nabi Biopharmaceuticals (the “Corporation”) and the Compensation Committee (the “Committee”) of the Board have determined that it is in the best interests of the Corporation and its shareholders for the Corporation to agree, as provided herein, to pay you termination compensation in the event you should leave the employ of the Corporation under the circumstances described below.
NABI BIOPHARMACEUTICALS Boca Raton, Florida 33487 June 13, 2006Letter Agreement • August 2nd, 2006 • Nabi Biopharmaceuticals • Biological products, (no disgnostic substances)
Contract Type FiledAugust 2nd, 2006 Company IndustryThis letter agreement (the “Agreement”) will confirm our agreement concerning the details of your separation from Nabi Biopharmaceuticals (“Nabi”).
DEFINITIVE CO-DEVELOPMENT & COMMERCIALIZATION AGREEMENT BETWEEN NABI BIOPHARMACEUTICALS AND KEDRION S.P.A.Agreement • August 2nd, 2006 • Nabi Biopharmaceuticals • Biological products, (no disgnostic substances) • New York
Contract Type FiledAugust 2nd, 2006 Company Industry JurisdictionThis Agreement (including the Schedules hereto, the “Agreement”) is made this 19th day of June 2006 (the “Effective Date”) by and between Nabi Biopharmaceuticals (together with its Affiliates, “Nabi”), a Delaware corporation, with its principal office at 5800 Park of Commerce Blvd. N.W. Boca Raton, FL 33487 USA, and Kedrion S.p.A. (together with its Affiliates, “Kedrion”), a corporation organized under the laws of Italy, with its principal office at 55020 Castelvecchio Pascoli (Lucca) Italy, each on behalf of itself and its Affiliates (as defined below).
RELOCATION/SIGN-ON BONUS REPAYMENT AGREEMENTRepayment Agreement • August 2nd, 2006 • Nabi Biopharmaceuticals • Biological products, (no disgnostic substances)
Contract Type FiledAugust 2nd, 2006 Company IndustryI, Jordan Siegel, agree that I will reimburse Nabi Biopharmaceuticals for relocation expenses and/or a sign-on bonus paid on my behalf, if I voluntarily terminate my employment with Nabi Biopharmaceuticals or I am terminated for cause within twelve (12) months after my start date. The following pro-rated repayment schedule will apply: